Top Tweets for #Bfly

I’ve initiated a position in $BFLY in response to the greatest medical imaging advancement I’ve personally ever seen. Midjourney just unveiled a full-body ultrasound scanner that produces MRI-like imaging with zero radiation, scans your entire body in under a minute, and costs virtually nothing to operate. This is one of the most significant leaps in medical imaging in decades. And the technology making it possible is Butterfly Network’s ultrasound-on-chip platform. 40 Butterfly imaging modules packed into a single machine. No radiation. No magnetic risk. Half a million sensors scanning simultaneously. This is what $BFLY has been building toward. The licensing deal powering this was disclosed in November 2025 and carries up to $74M in potential payments over five years. This is a massive validation of Butterfly’s Embedded business — licensing their semiconductor imaging technology directly into next-generation medical devices. The financials are quietly strong: • Q1 Revenue: $26.5M (+25% YoY) • FY26 Guidance: $117M-$121M (+20-24% YoY) • Cash: $138M • Burn: ~$23M/yr — roughly 6 years of runway Today at 12PM ET management presented at TD Cowen’s Medical Devices Emerging Growth Call. Listening closely for updates on enterprise adoption, AI subscriptions, and Embedded licensing progress. The Midjourney scanner is still early stage and faces regulatory hurdles. But $BFLY wins regardless through licensing revenue and growing adoption of their semiconductor platform. ~$1.5B market cap. Real technology. Real revenue growth. Real balance sheet. Not financial advice.